Are Research Peptides Australia and Brain Skin Bioregulators effective for cognitive wellness?

PE-22-28 Research Guide: TREK-1 Inhibition and Cognitive Health

June 12, 2026 infa sense

What is PE-22-28? (The Science of Spadin)

PE-22-28 is a synthetic 7-amino acid fragment derived from Spadin, an endogenous peptide naturally occurring in the brain. Specifically, it corresponds to residues 22–28 of the sortilin propeptide.

While the parent molecule, Spadin, already showed incredible promise in preclinical models, PE-22-28 represents a significant leap forward in potency and selectivity. In patch-clamp studies, PE-22-28 demonstrated a 300-fold higher potency in inhibiting TREK-1 channels compared to its predecessor. This “scientific luxury” molecule is engineered for researchers who demand precision and efficacy in their metabolic and cognitive studies.

Technical Classification:

  • Molecular Profile: Synthetic heptapeptide (7 amino acids).
  • Mechanism: Highly selective TREK-1 potassium (Kâ‚‚P) channel antagonist.
  • Primary Focus: Hippocampal neurogenesis and synaptogenesis.
  • Research Status: Preclinical investigational compound.

TREK-1: The Gateway to Neuro-Resilience

To understand why PE-22-28 is so transformative, we have to look at the TREK-1 channel. These are two-pore domain potassium channels found throughout the brain, particularly in the hippocampus: the region responsible for mood, learning, and memory.

In a standard biological state, TREK-1 channels act as a “brake” on neuronal excitability. While this is necessary for stability, overactive TREK-1 channels are linked to a “depression-prone” phenotype. By inhibiting these channels, PE-22-28 effectively removes this brake, allowing for enhanced neuronal signaling and the activation of critical survival pathways.

Abstract clinical illustration of neural pathways and synaptic connections, glowing blue nodes on a neutral grey background, minimalist and high-tech aesthetic, 16:9